First Trust Advisors LP bought a new stake in Phibro Animal Health Corp (NASDAQ:PAHC) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 15,359 shares of the company’s stock, valued at approximately $569,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. State of Alaska Department of Revenue raised its position in Phibro Animal Health by 80.9% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after purchasing an additional 1,650 shares during the last quarter. Municipal Employees Retirement System of Michigan raised its position in Phibro Animal Health by 3.6% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after purchasing an additional 150 shares during the last quarter. KBC Group NV bought a new position in Phibro Animal Health during the 2nd quarter valued at approximately $166,000. Victory Capital Management Inc. raised its position in Phibro Animal Health by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 5,380 shares of the company’s stock valued at $199,000 after purchasing an additional 807 shares during the last quarter. Finally, Capital Fund Management S.A. bought a new position in Phibro Animal Health during the 2nd quarter valued at approximately $210,000. 48.42% of the stock is owned by institutional investors.
Phibro Animal Health Corp (NASDAQ PAHC) opened at $32.75 on Friday. Phibro Animal Health Corp has a 52-week low of $26.10 and a 52-week high of $40.25. The stock has a market capitalization of $1,320.00, a P/E ratio of 21.34, a PEG ratio of 3.83 and a beta of 1.27. The company has a debt-to-equity ratio of 1.91, a current ratio of 3.26 and a quick ratio of 1.85.
Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Monday, November 6th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.01. Phibro Animal Health had a return on equity of 42.75% and a net margin of 8.87%. The firm had revenue of $193.40 million during the quarter, compared to analyst estimates of $189.89 million. During the same quarter in the prior year, the company earned $0.36 EPS. The business’s revenue was up 2.9% compared to the same quarter last year. research analysts expect that Phibro Animal Health Corp will post 1.57 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th will be given a $0.10 dividend. This represents a $0.40 annualized dividend and a dividend yield of 1.22%. The ex-dividend date of this dividend is Tuesday, December 5th. Phibro Animal Health’s dividend payout ratio is currently 23.53%.
A number of research analysts have commented on the company. Bank of America reaffirmed an “underperform” rating and set a $33.00 price target on shares of Phibro Animal Health in a research report on Wednesday, August 23rd. BidaskClub lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 23rd. Credit Suisse Group increased their target price on Phibro Animal Health from $36.00 to $37.00 and gave the stock an “outperform” rating in a research report on Thursday, August 31st. Piper Jaffray Companies set a $42.00 target price on Phibro Animal Health and gave the stock a “buy” rating in a research report on Friday, August 25th. Finally, Zacks Investment Research lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 1st. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the company’s stock. Phibro Animal Health presently has a consensus rating of “Hold” and a consensus price target of $38.25.
In related news, Director Gerald K. Carlson sold 5,400 shares of the company’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $36.27, for a total value of $195,858.00. Following the sale, the director now owns 5,400 shares in the company, valued at approximately $195,858. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Dean J. Warras sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $35.70, for a total value of $357,000.00. Following the completion of the sale, the insider now owns 10,000 shares in the company, valued at approximately $357,000. The disclosure for this sale can be found here. Insiders sold a total of 217,525 shares of company stock valued at $7,900,197 in the last three months. Corporate insiders own 51.88% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This article was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.dispatchtribunal.com/2017/12/09/first-trust-advisors-lp-invests-569000-in-phibro-animal-health-corp-pahc.html.
About Phibro Animal Health
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.